The Next Wave in Health Care Priority Setting.

Area of Science:

• Health Economics
• Pharmaceutical Policy
• Healthcare Management

Background:

• Rising healthcare costs are a global concern.
• New, highly effective drugs often come with significant price tags.
• Traditional cost-effectiveness analysis may not address affordability issues.

Purpose of the Study:

• To explore the emerging challenge of drug affordability in wealthy countries.
• To examine the limitations of cost-effectiveness in healthcare priority-setting.
• To discuss the implications of highly effective but costly new medications.

Main Methods:

• Analysis of current healthcare priority-setting frameworks.
• Evaluation of cost-effectiveness principles in the context of new drug implementation.
• Discussion of affordability challenges and potential alternative approaches.

Main Results:

• New drugs can be cost-effective yet unaffordable due to high implementation costs.
• The standard cost-effectiveness approach is challenged by these high-cost, high-value drugs.
• Affordability issues arise particularly when a drug targets a large patient population.

Conclusions:

• Healthcare systems face a dilemma between drug cost-effectiveness and overall affordability.
• Existing priority-setting methods may require re-evaluation to address budget constraints.
• Ensuring equitable access to innovative treatments necessitates innovative solutions beyond simple cost-effectiveness.